Skip to content

Effect of Oral Adenosine-triphosphate (ATP) on Human Muscle Performance

Effect of Oral ATP on Human Muscle Performance

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01141504
Enrollment
16
Registered
2010-06-10
Start date
2010-06-30
Completion date
2011-10-31
Last updated
2012-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Keywords

Supplemental ATP, Muscle Work Performed, Muscle Fatigue

Brief summary

Adenosine-triphosphate (ATP) serves as the sole energy source for muscle contraction. Therefore human performance of brief maximal exercise is limited, in part, by the availability of ATP to the contracting muscle. Because muscle ATP storage is small (enough to sustain maximal exercise for less than 1 second), factors that enhance either storage or resynthesis of ATP may have a positive impact on repeated muscle contractions. The current study will test the hypothesis that increasing ATP availability to muscle via oral supplementation will improve performance of repeated high intensity exercise as measured by a) work performed in each of the three 50 contraction fatigue tests, b) sum of total work performed, and c) percentage decrement in total work from the first to third third 50 contraction test.

Detailed description

To date we have studied 10 subjects who have followed through with all 3 of the original interventions (Placebo, 250 mg PeakATP/d and 400 mg PeakATP/d). Currently we have received approval and are expanding the study with 5 additional subjects who will receive the Placebo, 400 mg PeakATP/d and the 400 mg PealATP/d plus proprietary blend interventions.

Interventions

DIETARY_SUPPLEMENTPeakATP 250

The nutritional intervention provides for oral ingestion of 250 mg PeakATP per day

DIETARY_SUPPLEMENTPlacebo

Placebo capsules that are comparable in size and color to the active comparator for blinding purposes

DIETARY_SUPPLEMENTPeakATP 400

The nutritional intervention provides for oral ingestion of 400 mg PeakATP per day

DIETARY_SUPPLEMENTPeakATP 400 plus proprietary blend

The nutritional intervention provides for oral ingestion of 400 mg PeakATP per day plus a proprietary blend of additional nutrients

Sponsors

Iowa State University
CollaboratorOTHER
Metabolic Technologies Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* No major medical conditions; * Able to perform fatigue testing procedures; * Not currently taking prescription medications; * Not currently taking dietary supplements (a daily multi-vitamin not exceeding RDA is permitted)

Exclusion criteria

* Major medical condition affecting metabolism or general function; * Not able to perform fatigue testing; * Taking prescription medications; * Taking a dietary supplement other than a multi-vitamin not exceeding RDA

Design outcomes

Primary

MeasureTime frameDescription
Work PerformedMeasured after 15 days of interventionThe work and total work performed in 3 exercise fatigue tests given after 15 days of nutritional intervention.

Secondary

MeasureTime frameDescription
Decrease in work performed in each successive testMeasured after 15 days of interventionThe decrease in total work performed in each of 3 successive fatigue tests will be measured and used as a measure of muscle fatigability after 15 days of nutritional intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026